Examining the efficacy of a one-session cognitive-behavioral therapy treatment in a large group format for individuals with clinically relevant fear of flying

Examining the efficacy of a one-session cognitive-behavioral therapy treatment in a large group format for individuals with clinically relevant fear of flying - OST-clinical-fear of flying

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00031220

Enrollment

600

Registered

2023-02-23

Start date

2023-02-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F40.2 F40.0

Interventions

Group 1: One-session large group intervention, 150 participants, 8 hours, exposure therapy with 1.5 hour round-trip, add-on promoting of expectancy violation. Group 2: One-session large group interven

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: clinically relevant fear of flying in terms of a specific phobia or agoraphobia.

Exclusion criteria

Exclusion criteria: Psychiatric exclusion diagnoses (I.e.: manic or hypomanic episodes; disorders from the schizophrenia spectrum and severe post-traumatic stress disorder) and somatic factors (I.e.: pregnancy, severe infectious diseases, otitis media, cardiovascular disease, epilepsy and stroke, physical or mental disability).

Design outcomes

Primary

Measure	Time frame
1) Reduction of subjective fear of flying due to training : Captured by the FFS (Fear of Flying Scale), the FPS (Flying Phobia Screening Questionnaire), the AES (Anxiety Expectancy Scale Fear of Flying), DES (Danger Expectancy Scale Fear of Flying), and a one-item measure. Collection of these measures will occur after the consultation (T0), immediately before training (T1), after the training (T2), and two (T3) and six months (T4) after the training day. 2) Reduction of clinically relevant fear of flying due to training: Recorded via the presence of the diagnosis of "specific phobia" or "agoraphobia" using the Mini-DIPS: (Diagnostic Interview in Mental Disorders), at T0 and T4.	—

Measure

Time frame

1) Reduction of subjective fear of flying due to training : Captured by the FFS (Fear of Flying Scale), the FPS (Flying Phobia Screening Questionnaire), the AES (Anxiety Expectancy Scale Fear of Flying), DES (Danger Expectancy Scale Fear of Flying), and a one-item measure. Collection of these measures will occur after the consultation (T0), immediately before training (T1), after the training (T2), and two (T3) and six months (T4) after the training day. 2) Reduction of clinically relevant fear of flying due to training: Recorded via the presence of the diagnosis of "specific phobia" or "agoraphobia" using the Mini-DIPS: (Diagnostic Interview in Mental Disorders), at T0 and T4.

—

Secondary

Measure	Time frame
3) Reduction of agoraphobic cognitions through training: Will be captured by the ACQ (Agoraphobic Cognitions Questionnaire). Will be measured after the consultation (T0), immediately before the training (T1), after the training (T2), and two (T3) and six months (T4) after the training day. 4) Reduction in perceived symptom burden due to training: Will be captured by the DASS (Depression- Anxiety -Stress scales). Collection of these measures will occur after the consultation (T0), immediately before training (T1), after training (T2), and two (T3) and six months (T4) after the training day.	—

Measure

Time frame

3) Reduction of agoraphobic cognitions through training: Will be captured by the ACQ (Agoraphobic Cognitions Questionnaire). Will be measured after the consultation (T0), immediately before the training (T1), after the training (T2), and two (T3) and six months (T4) after the training day. 4) Reduction in perceived symptom burden due to training: Will be captured by the DASS (Depression- Anxiety -Stress scales). Collection of these measures will occur after the consultation (T0), immediately before training (T1), after training (T2), and two (T3) and six months (T4) after the training day.

—

Countries

Germany

Contacts

Public ContactAndré Wannemüller

Forschungs- und Behandlungszentrum der Ruhr-Universität Bochum

andre.wannemueller@rub.de+49 234 3223106

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 27, 2026